MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 69 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,100,405 | +2888.7% | 98,114 | +2346.7% | 0.02% | +2200.0% |
| Q2 2023 | $103,739 | +112.3% | 4,010 | +97.1% | 0.00% | – |
| Q1 2023 | $48,857 | -94.1% | 2,034 | -95.2% | 0.00% | -100.0% |
| Q2 2022 | $824,000 | +136.8% | 42,349 | +168.3% | 0.01% | +66.7% |
| Q1 2022 | $348,000 | +728.6% | 15,783 | +495.8% | 0.00% | – |
| Q4 2021 | $42,000 | -59.6% | 2,649 | -49.4% | 0.00% | -100.0% |
| Q3 2021 | $104,000 | +271.4% | 5,240 | +223.9% | 0.00% | – |
| Q2 2021 | $28,000 | -82.9% | 1,618 | -80.4% | 0.00% | -100.0% |
| Q1 2021 | $164,000 | -3.0% | 8,259 | -14.8% | 0.00% | 0.0% |
| Q4 2020 | $169,000 | +8350.0% | 9,693 | +9593.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |